Feedback
TORNTPHARM 
Reputation: 642,681 • Jul 21, 2023 8:21 PM
Glenmark Life Sciences Q1 Results: Firm posts 25% rise in profit on API strength
The company, spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, said total revenue from operations climbed 18% to 5.87 billion rupees during the quarter, with regulated markets including the U.S., Europe and India contributing 78%.
The Economic Times
Vote
Comment
Share
NSE:TORNTPHARM price when posted: 1,937.5